ASTX029
Phase 2- Indications
- Cancer
Company intelligence / Profile preview
Mosaic Pharma
Boulder, Colorado, United Statesmosaic-tx.com ↗
- Ownership
- Private
- Employees
- ~39
- Development stage
- Phase 2
01
Overview
Mosaic Biosciences is a CRO/service provider specializing in discovering and validating novel protein and antibody therapeutics for partners, using advanced discovery platforms and multidisciplinary expertise for preclinical stage research.
- Therapeutic areas
- Other
- Modalities
- ProteinMonoclonal antibodyAntibodyNucleic acid-based therapeutics
- Industry
- Drug Discovery Services
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Not publicly specified (works with biopharma and academic partners on a service model)
Beyond the preview
Go deeper on Mosaic Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mosaic Pharma.